상품명칭 |
Idarubicin HCl |
영문 이름 |
Idarubicin HCl; Idarubicin Hydrochloride; (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside hydrochloride (1:1); (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride (1:1); (7S-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride |
분자식 |
C26H28ClNO9 |
분자량 |
533.9548 |
InChI |
InChI=1/C26H27NO9.ClH/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31;/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3;1H/t10-,15-,16-,17-,21+,26-;/m0./s1 |
cas번호 |
57852-57-0 |
EC번호 |
260-990-7 |
분자 구조 |
|
비등점 |
725.4°C at 760 mmHg |
인화점 |
392.5°C |
증기압 |
4.34E-22mmHg at 25°C |
위험성 표시 |
T+:Very toxic;
|
리스크 규칙 |
R60:;
R61:;
R28:;
R40:;
|
보안 규칙 |
S53:;
S45:;
|
|